Search alternatives:
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
laser decrease » larger decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
laser decrease » larger decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
-
1501
-
1502
-
1503
-
1504
-
1505
-
1506
-
1507
-
1508
Sign of regression effects predicted by a hypothesis of a true increasing or decreasing effect and a hypothesis of spurious associations.
Published 2025“…<p>Sign of regression effects predicted by a hypothesis of a true increasing or decreasing effect and a hypothesis of spurious associations.…”
-
1509
-
1510
-
1511
Blocking CD88 decreased ANCA antigen translocation, ANCA-induced respiratory burst and degranulation in C5a-primed neutrophils.
Published 2013“…C and D: blocking CD88 decreased C5a-primed neutrophils for ANCA-induced respiratory burst. …”
-
1512
GSK360A increased kidney EPO and brain VEGF mRNA after stroke.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1513
Effect of GSK360A on APA learning performance 3 weeks after tMCAO stroke.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1514
The blood plasma, kidney, and brain concentration levels (ng/ml) of GSK360A presented for 5 and 24 hours after GSK360A (30 mg/kg) was administered orally by gavage.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1515
Body weight was measured over the course of the study.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1516
Hypoxia-inducible factors (HIFs) are transcription factors that respond to changes in environmental oxygen.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1517
TTC staining of forebrain 2 mm thick sections conducted 4 weeks after tMCAO stroke (1 week after APA testing).
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1518
Overall schematic of basic experimental studies and designs.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1519
The chemical structure and the enzymatic and cellular activity of GSK360A.
Published 2017Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”
-
1520